Skip to content

The mechanism research of transcutaneous electrical stimulation of auricular acupuncture points in patients with mild cognition impairment

The mechanism research of the three networks on mild cognition impairment utilizing transcutaneous electrical stimulation of auricular acupuncture points

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038868
Enrollment
Unknown
Registered
2020-10-08
Start date
2020-10-16
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognition impairment

Interventions

Sponsors

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.At least half a year of local residence at the time of investigation); 2.Han Nationality; 3.Right-handed.

Exclusion criteria

Exclusion criteria: 1.Nervous system diseases: cerebrovascular disease, encephalitis, brain tumor, brain trauma, epilepsy, Parkinson's disease and other neurological diseases that lead to cognitive decline; 2.Metabolic diseases: anemia, thyroid dysfunction, folic acid and vitamin B12 deficiency lead to cognitive decline; 3.Severe mental illness, such as severe depression 4.History of gas poisoning; 5.History of general anesthesia; 6.Dementia; 7.Acute or serious life-threatening illness; 8.Patients who have severe vision, hearing or language problems and can not complete neuropsychological assessment.

Design outcomes

Primary

MeasureTime frame
Montreal cognitive assessment, MOCA-B;

Secondary

MeasureTime frame
AVLT-H;STT-A&B;AFT;BNT;fMRI;EEG;PSQI;HAMD;HAMA;

Countries

China

Contacts

Public ContactLei Wang

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences

tommyadison123@163.com+86 10 64089407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026